Protagenic Therapeutics, Inc. (PTIX)

NASDAQ: PTIX · Real-Time Price · USD

3.510

+0.450 (14.71%)

At close: May 13, 2025, 4:00 PM

3.480

-0.030 (-0.85%)

Pre-market: May 14, 2025, 8:28 AM EDT

Protagenic Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Selling, General & Admin	1.76	1.21	1.97	3	1.85	Upgrade
Research & Development	3.94	3.32	1.59	1.14	0.7	Upgrade
Operating Expenses	5.7	4.53	3.56	4.14	2.55	Upgrade
Operating Income	-5.7	-4.53	-3.56	-4.14	-2.55	Upgrade
Interest Expense	-	-0.11	-0.14	-0.5	-0.25	Upgrade
Interest & Investment Income	0.04	0.26	0.19	0.03	0	Upgrade
Other Non Operating Income (Expenses)	-	-	-	0.08	0.25	Upgrade
EBT Excluding Unusual Items	-5.66	-4.37	-3.51	-4.52	-2.55	Upgrade
Gain (Loss) on Sale of Investments	0.05	-0.63	-0.05	-0	-	Upgrade
Other Unusual Items	0.08	-	-	-	-	Upgrade
Pretax Income	-5.53	-5	-3.56	-4.52	-2.55	Upgrade
Net Income	-5.53	-5	-3.56	-4.52	-2.55	Upgrade
Net Income to Common	-5.53	-5	-3.56	-4.52	-2.55	Upgrade
Shares Outstanding (Basic)	0	0	0	0	0	Upgrade
Shares Outstanding (Diluted)	0	0	0	0	0	Upgrade
Shares Change (YoY)	12.78%	0.62%	17.17%	42.57%	0.76%	Upgrade
EPS (Basic)	-15.79	-16.11	-11.53	-17.18	-13.80	Upgrade
EPS (Diluted)	-15.79	-16.11	-11.53	-17.18	-13.80	Upgrade
Free Cash Flow	-4.22	-3.85	-2	-2.8	-1.35	Upgrade
Free Cash Flow Per Share	-12.05	-12.42	-6.47	-10.63	-7.30	Upgrade
EBITDA	-5.65	-4.5	-3.56	-4.14	-2.55	Upgrade
D&A For EBITDA	0.05	0.03	0	0	0	Upgrade
EBIT	-5.7	-4.53	-3.56	-4.14	-2.55	Upgrade

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q